Amalgamated Bank Adma Biologics, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 68,084 shares of ADMA stock, worth $1.06 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,084
Previous 67,665
0.62%
Holding current value
$1.06 Million
Previous $1.23 Million
18.99%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ADMA
# of Institutions
396Shares Held
191MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$289 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$199 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$187 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$91.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.04B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...